RT Journal Article
SR Electronic
T1 Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.23.20236810
DO 10.1101/2020.11.23.20236810
A1 Díez-Manglano, Jesús
A1 Marquínez, Marta Nataya Solís
A1 García, Andrea Álvarez
A1 Alcalá-Rivera, Nicolás
A1 Riesco, Irene Maderuelo
A1 Aseguinolaza, Martín Gericó
A1 Pérez, José Luis Beato
A1 Bailon, Manuel Mendez
A1 Ruiz, Ane Elbire Labirua-Iturburu
A1 Gómez, Miriam García
A1 Cilleros, Carmen Martinez
A1 Fontan, Paula Maria Pesqueira
A1 Vázquez, Lucy Abella
A1 Encinar, Julio César Blázquez
A1 Boixeda, Ramon
A1 Sánchez, Ricardo Gil
A1 de la Peña Fernández, Andrés
A1 Amigo, Jose Loureiro
A1 Sevilla, Joaquin Escobar
A1 Garcia, Marcos Guzmán
A1 Escalante, María Dolores Martín
A1 Gamboa, Jeffrey Oskar Magallanes
A1 Gonzalez, Angel Luís Martínez
A1 Bermejo, Carlos Lumbreras
A1 Santos, Juan Miguel Antón
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/11/24/2020.11.23.20236810.abstract
AB Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW).Methods Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20-65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality.Results As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p=0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.219, 95%CI 0.069-0.693, p=0.01). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001).Conclusions Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was carried out in accordance with the Declaration of Helsinki. The processing of personal data strictly complied with Spanish Law 14/2007, of July 3, on Biomedical Research and Spanish Organic Law 3/2018, of 5 December, on the Protection of Personal Data and the Guarantee of Digital Rights.The study was approved by the Provincial Research Ethics Committee of Malaga (Spain) following the recommendation of the Spanish Agency of Medicines and Medical Products (AEMPS, for its initials in Spanish).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used data of the SEMI-COVID-19-Registry, which has been previously described (Casas JM. Rev Clin Esp 2020; 220: 480-94). Due to legal issues, some restrictions apply to our data and they cannot be uploaded to any public server. However, we can share the data as a request to the Principal Investigator of the EpiChron Cohort Study at covid-gestion@reginus.es.